Navasa M - Search Results

1

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period.

Mariño Z, Crespo G, D'Amato M, Brambilla N, Giacovelli G, Rovati L, Costa J, Navasa M, Forns X. Mariño Z, et al. Among authors: navasa m. J Hepatol. 2013 Mar;58(3):415-20. doi: 10.1016/j.jhep.2012.09.034. Epub 2012 Oct 11. J Hepatol. 2013. PMID: 23063567 Clinical Trial.

2

Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure.

Salmerón JM, Titó L, Rimola A, Mas A, Navasa MA, Llach J, Ginès A, Ginès P, Arroyo V, Rodés J. Salmerón JM, et al. Among authors: navasa ma. J Hepatol. 1992 Mar;14(2-3):280-5. doi: 10.1016/0168-8278(92)90171-k. J Hepatol. 1992. PMID: 1500692 Clinical Trial.

3

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: navasa m. J Hepatol. 1990 Sep;11(2):189-95. doi: 10.1016/0168-8278(90)90112-5. J Hepatol. 1990. PMID: 2123914 Clinical Trial.

4

Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.

Bosch J, Groszmann RJ, García-Pagán JC, Terés J, García-Tsao G, Navasa M, Mas A, Rodés J. Bosch J, et al. Among authors: navasa m. Hepatology. 1989 Dec;10(6):962-8. doi: 10.1002/hep.1840100612. Hepatology. 1989. PMID: 2511136 Clinical Trial.

5

Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.

Silva G, Gomis R, Bosch J, Casamitjana R, Mastai R, Navasa M, Rivera F, Rodés J. Silva G, et al. Among authors: navasa m. J Hepatol. 1988 Jun;6(3):325-31. doi: 10.1016/s0168-8278(88)80049-7. J Hepatol. 1988. PMID: 3392382

6

[Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature].

Salgado M, Sans M, Forns X, Bruguera M, Castells A, Navasa M, Rodés J. Salgado M, et al. Among authors: navasa m. Gastroenterol Hepatol. 1995 Mar;18(3):132-5. Gastroenterol Hepatol. 1995. PMID: 7621289 Review. Spanish.

7

Cyclosporin A increases the biochemical markers of bone remodeling in primary biliary cirrhosis.

Guañabens N, Parés A, Navasa M, Martínez de Osaba MJ, Hernández ME, Muñoz J, Rodés J. Guañabens N, et al. Among authors: navasa m. J Hepatol. 1994 Jul;21(1):24-8. doi: 10.1016/s0168-8278(94)80132-0. J Hepatol. 1994. PMID: 7963418 Clinical Trial.

8

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.

Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodés J. Follo A, et al. Among authors: navasa m. Hepatology. 1994 Dec;20(6):1495-501. doi: 10.1002/hep.1840200619. Hepatology. 1994. PMID: 7982650

9

Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.

Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, Boix L, Visa J, Rodés J. Castells A, et al. Among authors: navasa m. Hepatology. 1993 Nov;18(5):1121-6. Hepatology. 1993. PMID: 8225217

10

Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis.

Navasa M, Feu F, García-Pagán JC, Jiménez W, Llach J, Rimola A, Bosch J, Rodés J. Navasa M, et al. Hepatology. 1993 Mar;17(3):355-60. Hepatology. 1993. PMID: 8444409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters